Increasing Use of Compassionate Use/Managed Access Channels to Obtain Medicines for Use in COVID‐19

por Aliu, Paul, Sarp, Séverine, Fitzsimmons, Paige
Publicado 2020

An approach to data collection in compassionate use/managed access

por Sarp, Séverine, Reichenbach, Ramona, Aliu, Paul
Publicado 2022

Octreotide s.c. depot provides sustained octreotide bioavailability and similar IGF-1 suppression to octreotide LAR in healthy volunteers

por Tiberg, Fredrik, Roberts, John, Cervin, Camilla, Johnsson, Markus, Sarp, Severine, Tripathi, Anadya Prakash, Linden, Margareta
Publicado 2015

Long-term safety of long-acting octreotide in patients with diabetic retinopathy: results of pooled data from 2 randomized, double-blind, placebo-controlled phase 3 studies

por Pivonello, Rosario, Muscogiuri, Giovanna, Holder, Geoffrey, Paul, Michaela, Sarp, Severine, Lesogor, Anastasia, Jordaan, Pierre, Eisinger, Johannes, Colao, Annamaria
Publicado 2017

International Country-Level Trends, Factors, and Disparities in Compassionate Use Access to Unlicensed Products for Patients With Serious Medical Conditions

por Aliu, Paul, Sarp, Séverine, Reichenbach, Ramona, Behr, Sigrid, Fitzsimmons, Paige, Shamlajee, Mansurahmad, Kola, Surya Prakash, Nunes Radimerski, Samantha, Scosyrev, Emil
Publicado 2022